As of 11:31 AM on the 21st, Celltrion is trading at 365,000 KRW, up 2.53% from the previous day. This marks a 21.26% increase compared to November 23. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have a tentative net purchase of 145,869 shares of Celltrion, while institutions have a net sale of 16,000 shares. Over the past five days, individual investors have net purchased 169,646 shares, whereas foreigners and institutions have net sold 75,495 shares and 128,373 shares, respectively.


On December 20, Celltrion made headlines in the market with the issue titled "Capture the global 7 trillion KRW market... Global autoimmune disease treatment..."


Hot Picks Today

About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column] About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing